iNGEN CRO
Business Services · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
456 St Kilda Rd, Melbourne, Victoria, 30...Website
www.ingenucro.comRevenue
<$5 MillionIndustry
About iNGEN CRO
iNGENū is an Australian contract research organisation (CRO) that specializes in physician-led, FDA-ready clinical trials, offering services at 80-90% lower costs compared to US CROs. The company utilizes proprietary technology to streamline clinical operations, data management, and regulatory affairs, ensuring high-quality outcomes for biotech and pharmaceutical sponsors worldwide. With expertise across various therapeutic areas, including oncology and rare diseases, iNGENū is designed to handle complex clinical studies that other CROs may avoid. The organization is recognized for its innovative approach and has received accolades for its customer value leadership in the Asia-Pacific biotech sector.Explore more
SIC Code 87,873NAICS Code 54,541Show more
iNGEN CRO Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to iNGEN CRO
Compare insights from companies similar to iNGEN CRO, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Top Business Services Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding iNGEN CRO
Sign Up For FreeTo access detailed company insights
iNGENū is an Australian contract research organisation (CRO) that specializes in physician-led, FDA-ready clinical trials, offering services at 80-90% lower costs compared to US CROs. The company utilizes proprietary technology to streamline clinical operations, data management, and regulatory affairs, ensuring high-quality outcomes for biotech and... Read More
